Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013 (2013), Article ID 351292, 5 pages
Case Report

Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma

1Division of Hematology and Oncology, Department of Medicine, Edah Hospital, No. 1, Yi-Da Road, Yen-Tsao District, P.O. Box 824, Kaohsiung, Taiwan
2Department of Radiation Oncology, Edah Hospital, Kaohsiung, Taiwan
3Department of Nuclear Medicine, Edah Hospital, Kaohsiung, Taiwan

Received 15 July 2013; Accepted 12 September 2013

Academic Editors: R. Lowenthal and M. Nagasawa

Copyright © 2013 Hung-Bo Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hung-Bo Wu, Shyh-An Yeh, and Huei-Yung Chen, “Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma,” Case Reports in Hematology, vol. 2013, Article ID 351292, 5 pages, 2013. doi:10.1155/2013/351292